Possible use of the new antiretroviral drug a fixed-dose combination of TDF/RPV/FTC registered as Evipler for the treatment of HIV-1 infection (Record of the meeting)
- 作者: - -
- 期: 编号 3 (2014)
- 页面: 79-80
- 栏目: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/278053
- ID: 278053
如何引用文章